Drawing for MULTIVIR

USPTO serial 87741105

MULTIVIR

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
FITZSIMONS, MICHAEL R
Law office
TMEG LAW OFFICE 103 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with MULTIVIR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Adam S. Baldridge

Adam S. Baldridge BAKER DONELSON BEARMAN CALDWELL & BER165 MADISON AVE STE 2000MEMPHIS, TN 38103UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemical, biochemical and biological gene therapy preparations for the modulation and identification of gene and protein expression for research, laboratory, pharmaceutical research, clinical, medical laboratory and manufacturing uses, in the field of viruses genetically modified for gene therapy, cancer treatment and vaccinesACTIVE—
005Diagnostic and therapeutic gene therapy preparations for the modulation of gene and protein expression for medical treatment purposes, in the field of viruses genetically modified for gene therapy, cancer treatment and vaccinesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
May 27, 2021MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
May 27, 2021ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Nov 11, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 11, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 11, 2020CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 29, 2020SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Oct 29, 2020AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Oct 14, 2020IUAFUSE AMENDMENT FILED—
Oct 14, 2020EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Apr 14, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 28, 2020TMBNTTAB RELEASE CASE TO TRADEMARKS—
Feb 28, 2020OP.TOPPOSITION TERMINATED NO. 999999—
Feb 28, 2020OP.DOPPOSITION DISMISSED NO. 999999—
Nov 19, 2018OP.IOPPOSITION INSTITUTED NO. 999999—
Jun 20, 2018ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
May 22, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 22, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 2, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 18, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 11, 2018DOCKASSIGNED TO EXAMINER—
Jan 17, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 5, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance